InBody Co.,Ltd (KOSDAQ:041830)

Market Cap	349.92B
Revenue (ttm)	217.55B
Net Income (ttm)	30.62B
Shares Out	12.19M
EPS (ttm)	2,409.58
PE Ratio	11.91
Forward PE	10.64
Dividend	400.00 (1.39%)
Ex-Dividend Date	Mar 28, 2025

Volume	44,232
Average Volume	32,238
Open	28,900
Previous Close	28,750
Day's Range	28,000 - 28,900
52-Week Range	20,700 - 29,700
Beta	0.50
RSI	62.93
Earnings Date	Nov 11, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 1996
• Employees: 342
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.